Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Vaccinations01:51

Vaccinations

52.4K
Overview
52.4K
Cross-reactivity00:42

Cross-reactivity

33.3K
Overview
33.3K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Burden of HIV and hepatitis B and C viruses in incoming Venezuelan migrants at the Colombian border: a laboratory-based cross-sectional study, 2021-2023.

Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases·2026
Same author

Impact of SARS-CoV-2 Infection on Pulmonary Function in the PURE-Colombia Cohort: A Comparative Analysis with Pre-COVID Values and Non-COVID-19 Controls.

Journal of clinical medicine·2026
Same author

Evaluating Three Rapid Tests for Dengue in Febrile Patients in a Dengue-Endemic Area.

Tropical medicine & international health : TM & IH·2026
Same author

Knowledge, Attitudes, and Practices Regarding Dengue, Vector Control, and Vaccine Acceptance Among the Mexican Population.

Cureus·2026
Same author

Knowledge, Attitudes, Practices and Perceptions of the Eco-Bio-Social Determinants of Dengue Transmission in São Paulo, Brazil: A Mixed-Methods Study.

Tropical medicine & international health : TM & IH·2025
Same author

Immune thrombocytopenic purpura following mRNA.

Revista Cuidarte·2025

Related Experiment Video

Updated: Feb 28, 2026

A Simple Flow Cytometry Based Assay to Determine In Vitro Antibody Dependent Enhancement of Dengue Virus Using Zika Virus Convalescent Serum
07:06

A Simple Flow Cytometry Based Assay to Determine In Vitro Antibody Dependent Enhancement of Dengue Virus Using Zika Virus Convalescent Serum

Published on: April 10, 2018

9.2K

ADE and dengue vaccination.

Ruth Aralí Martínez-Vega1, Gabriel Carrasquila2, Expedito Luna3

  • 1Universidad Industrial de Santander, Bucaramanga, Colombia.

Vaccine
|June 18, 2017
PubMed
Summary

This study challenges the concept of an enhancing vaccine for Dengue virus (DENV). It presents objections to the underlying epidemiological model and offers data contradicting the enhancing vaccine theory for Dengvaxia® (CYD).

Keywords:
DengueImmunityPathogenesisVaccine

More Related Videos

A Murine Model of Dengue Virus-induced Acute Viral Encephalitis-like Disease
04:23

A Murine Model of Dengue Virus-induced Acute Viral Encephalitis-like Disease

Published on: April 28, 2019

7.2K
Author Spotlight: Development of a Smartphone-Enhanced Paper-Based Device for Rapid Dengue NS1 Detection
06:00

Author Spotlight: Development of a Smartphone-Enhanced Paper-Based Device for Rapid Dengue NS1 Detection

Published on: January 26, 2024

2.1K

Related Experiment Videos

Last Updated: Feb 28, 2026

A Simple Flow Cytometry Based Assay to Determine In Vitro Antibody Dependent Enhancement of Dengue Virus Using Zika Virus Convalescent Serum
07:06

A Simple Flow Cytometry Based Assay to Determine In Vitro Antibody Dependent Enhancement of Dengue Virus Using Zika Virus Convalescent Serum

Published on: April 10, 2018

9.2K
A Murine Model of Dengue Virus-induced Acute Viral Encephalitis-like Disease
04:23

A Murine Model of Dengue Virus-induced Acute Viral Encephalitis-like Disease

Published on: April 28, 2019

7.2K
Author Spotlight: Development of a Smartphone-Enhanced Paper-Based Device for Rapid Dengue NS1 Detection
06:00

Author Spotlight: Development of a Smartphone-Enhanced Paper-Based Device for Rapid Dengue NS1 Detection

Published on: January 26, 2024

2.1K

Area of Science:

  • Virology
  • Epidemiology
  • Immunology

Background:

  • Dengvaxia® (CYD), a Dengue virus (DENV) vaccine, faces scrutiny regarding its performance and safety.
  • Recent publications have questioned the efficacy and security of this widely registered vaccine.

Purpose of the Study:

  • To critically analyze the concept of an "enhancing vaccine" in the context of DENV.
  • To present arguments against the epidemiological model supporting the enhancing vaccine theory.
  • To provide data that contradicts the notion of vaccine enhancement for DENV.

Main Methods:

  • Conceptual analysis of the "enhancing vaccine" hypothesis.
  • Critique of the epidemiological models used to support the enhancing vaccine concept.
  • Presentation of empirical data relevant to DENV vaccine response.

Main Results:

  • The study identifies flaws in the epidemiological models underpinning the enhancing vaccine concept.
  • Data presented suggests that Dengvaxia® (CYD) does not exhibit characteristics of an enhancing vaccine.
  • The findings challenge the validity of the enhancing vaccine theory for DENV.

Conclusions:

  • The concept of an enhancing vaccine for Dengue virus, as currently modeled, is contested.
  • Empirical evidence presented does not support the enhancing vaccine hypothesis for Dengvaxia® (CYD).
  • Further research and re-evaluation of DENV vaccine strategies are warranted.